Back to Top
GEN Protocols


Soft Skills Needed in the Biotech Workforce

Date: July 18, 2022, 11:00 am - 12:00 pm ET

View on Demand

Being a professional in a successful life science company--be it a CRO, a CDMO, a startup, a mid- to medium-sized biotech firm, or an established company with a track record of popular products--requires much more than academic credentials, research expertise and technical knowhow. Soft skills are the competencies required to perform effectively in a biotech team and understand the corporate culture. These are complementary to technical knowledge necessary to acquire and maintain employment in the biotech and biopharma industry. Active listening, critical thinking, time management, negotiation, conflict management, networking are just some examples of soft skills needed in the biotech workplace. Knowing and practicing effective soft skills can help you navigate the unwritten rules of the business world and are essential in growing your professional career. 

Due to an overwhelming number of requests from our audience transitioning to jobs in the biotech industry, in this GEN Protocols Mixer, we will discuss soft skills needed to fit into the constantly evolving corporate culture of the biotech and biopharma workforce. 


View on Demand

Tim Hunt serves as a member of the executive team at Xilio Therapeutics and oversees human resources, communications and other strategic initiatives. Tim has a track record of building and leading exceptional teams and driving strategic initiatives at the intersection of global communications, policy, and corporate culture that favorably build companies, engage employees, establish reputations, and improve the business climate in the life sciences sector. Before joining Xilio in 2021, Tim served as the Chief Corporate Affairs Officer at Editas Medicine, a leading genome editing company, where he oversaw global policy, government affairs, bioethics, communications, market development, culture, and human resource initiatives.  He previously worked for Cubist Pharmaceuticals and Biogen.